|
C11ORF58 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.98450000046913E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.28570000038175E-07 |
| Normal-vs-Stage2 |
3.185900E-02 |
| Normal-vs-Stage3 |
2.656000E-02 |
| Normal-vs-Stage4 |
1.297570E-03 |
| Stage1-vs-Stage2 |
3.824200E-01 |
| Stage1-vs-Stage3 |
1.703640E-01 |
| Stage1-vs-Stage4 |
7.846400E-01 |
| Stage2-vs-Stage3 |
8.048000E-01 |
| Stage2-vs-Stage4 |
5.886800E-01 |
| Stage3-vs-Stage4 |
3.632000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.52230000050046E-07 |
| Normal-vs-AfricanAmerican |
1.099830E-03 |
| Normal-vs-Asian |
9.827600E-02 |
| Caucasian-vs-AfricanAmerican |
1.990800E-01 |
| Caucasian-vs-Asian |
5.264400E-01 |
| AfricanAmerican-vs-Asian |
8.750600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.2059999988121E-08 |
| Normal-vs-Female |
5.530000E-02 |
| Male-vs-Female |
4.583100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.558420E-03 |
| Normal-vs-Extreme_Weight |
1.79010000045388E-07 |
| Normal-vs-Obese |
6.565700E-04 |
| Normal-vs-Extreme_Obese |
5.66650000000113E-05 |
| Normal_Weight-vs-Extreme_Weight |
2.561200E-01 |
| Normal_Weight-vs-Obese |
8.896000E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.902000E-01 |
| Extreme_Weight-vs-Obese |
1.519170E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.895200E-01 |
| Obese-vs-Extreme_Obese |
1.480560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.650400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.58939999999453E-05 |
| Normal-vs-Age(61-80Yrs) |
1.01579999967072E-08 |
| Normal-vs-Age(81-100Yrs) |
3.9334000000002E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.257600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.000700E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.436460E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.193700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.509020E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.398000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.52479999924327E-08 |
| Normal-VS-Type2 PRCC |
2.71789999994887E-06 |
| Normal-VS-KIRP CIMP |
6.332800E-01 |
| Normal-VS-Unclassified PRCC |
7.169600E-04 |
| Type1 PRCC-VS-Type2 PRCC |
8.200800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.299830E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.773800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.800900E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
6.269200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.500080E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.26339999964686E-07 |
| Normal-vs-N1 |
3.743200E-01 |
| Normal-vs-N2 |
7.920500E-03 |
| N0-vs-N1 |
2.298000E-02 |
| N0-vs-N2 |
9.317600E-01 |
| N1-vs-N2 |
2.882600E-01 |
|
|
